Why the study?
Does sildenafil attenuate ventricular remodeling and improve function in a rat model of aortic regurgitation?
Does sildenafil attenuate ventricular remodeling and improve function in a rat model of aortic regurgitation?
Sildenafil attenuates left ventricular remodeling and improves fractional shortening in a rat model of aortic regurgitation when treatment is initiated early.
Answers are grounded in this paper and cite their sources.
Supports PDE5 inhibition to limit remodeling in experimental AR; hypothesis-generating and leaves open translation to patients.
BACKGROUND: Currently there is no reliable medical treatment for aortic regurgitation (AR). METHODS: Thirty-nine Sprague-Dawley rats underwent creation of AR or sham operation. Treated rats were assigned to early or late institution of sildenafil therapy (100 mg/kg/day) for a total of 10 weeks. Treatment-effects were measured by serial echocardiography, invasive hemodynamic measurements, and tissue analysis. RESULTS: Rats assigned to early treatment developed less remodeling than untreated rats. Thus, left ventricular (LV) dilation was blunted by sildenafil with end-systolic diameter being significantly smaller (6.6 ± 0.4 vs. 7.7 ± 0.4 mm, respectively, p < 0.05). Also, LV wall thickness was significantly decreased in treated rats compared to controls (2.23 ± 0.08 vs. 2.16 ± 0.05 mm, p < 0.01). Fractional shortening was improved by treatment (p < 0.05). Myocardial fibrosis was borderline decreased by treatment (p = 0.09). Akt was increased in treated compared to controls (p < 0.05). CONCLUSION: Sildenafil slightly inhibits LV remodeling and improves fractional shortening in rats with AR when treatment is initiated early.
No takes yet. Share an insight, caveat, or question.
Eskesen et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: